NADH-dependent reduction of sulphamethoxazole hydroxylamine in dog and human liver microsomes

References

• BLAISDELL, J., GOLDSTEIN, J. A. and BAI, S. A., 1998, Isolation of a new canine cytochrome P450 cDNA from the cytochrome P450 2C subfamily (CYP2 C41) and evidence for polymorphic differences in its expression. Drug Metabolism and Disposition, 26, 278–283.
   PubMed Web of Science ®Google Scholar
• BORN, S. L., FRASER, D. J., HARLOW, G. R. and HALPERT, J. R., 1996, Escherichia coli expression and substrate specificities of canine cytochrome P450 3Al2 and rabbit cytochrome P450 3A6. Journal of Pharmacology and Experimental Therapeutics, 278, 957–963.
   PubMedGoogle Scholar
• BRIDGES, J. and WILLIAMS, R., 1963, Species differences in the acetylation of sulphanilamide. Biochemical Journal, 87, 19P.
   Google Scholar
• CALDWELL, J., 1980, Comparative aspects of detoxication in mammals. In W. Jakoby (ed.), Enzymatic Basis of Detoxication (New York: Academic Press), pp. 85–114.
   Google Scholar
• CHAURET, N., GAUTHIER, A., MARTIN, J. and NICOLL-GRIFFIN, D. A., 1997, In vitro comparison of cytochrome P450-mediated metabolic activities in human, dog, cat, and horse. Drug Metabolism and Disposition, 25,1130–1136.
   PubMed Web of Science ®Google Scholar
• CLEMENT, B., DEMESMAEKER, M. and LINNE, S., 1996, Microsomal catalysed N-hydroxylation of guanabenz and reduction of the N-hydroxylated metabolite: characterization of the two reactions and genotoxic potential of guanoxabenz. Chemical Research in Toxicology, 9, 682–688.
   PubMed Web of Science ®Google Scholar
• CLEMENT, B. and JUNG, F., 1994, N-hydroxylation of the antiprotozoal drug pentamidine catalysed by rabbit liver cytochrome P-450 2C3 or human liver microsomes, microsomal retroreduction, and further oxidative transformation of the formed amidoximes. Drug Metabolism and Disposition, 22, 486–497.
   PubMed Web of Science ®Google Scholar
• CLEMENT, B., LOMB, R. and MOLLER, W., 1997, Isolation and characterization of the protein components of the liver microsomal 02-insensitive NADH-benzamidoxime reductase. Journal of Biological Chemistry, 272, 19615–19620.
   PubMed Web of Science ®Google Scholar
• CLEMENT, B., SCHULTZE-MOSGAU, M.-H. and WOHLERS, H., 1993, Cytochrome P450 dependent N-hydroxylation of a guanidine (debrisoquine), microsomal catalysed reduction and further oxidation of the N-hydroxy-guanidine metabolite to the urea derivative. Biochemical Phar-macology, 46, 2249–2267.
   Google Scholar
• CORNISH-BOWDEN, A., 1995, Fundamentals of Enzyme Kinetics (London: Portland).
   Google Scholar
• CRIBB, A. E., 1989, Idiosyncratic reactions to sulphonamides in dogs..7AVMA, 195, 1612–1614.
   Google Scholar
• CRIBB, A. E., LEE, B. L., TREPANIER, L. A. and SPIELBERG, S. P., 1996, Adverse reactions to sulphonamide and sulphonamide-trimethoprim antimicrobials: clinical syndromes and patho-genesis. Advances in Drug Reactions and Toxicological Reviews, 15, 9–50.
   PubMed Web of Science ®Google Scholar
• CRIBB, A. E. and SPIELBERG, S. P., 1990a, Hepatic microsomal metabolism of sulphamethoxazole to the hydroxylamine. Drug Metabolism and Disposition, 18, 784–787.
   PubMed Web of Science ®Google Scholar
• CRIBB, A. E. and SPIELBERG, S. P., 1990b, An in vitro investigation of predisposition to sulphonamide idiosyncratic toxicity in dogs. Veterinary Research Communications, 14, 241–252.
   PubMed Web of Science ®Google Scholar
• CRIBB, A. E., SPIELBERG, S. P. and GRIFFIN, G. P., 1995, N4-hydroxylation of sulphamethoxazole by cytochrome P450 of the cytochrome P4502C subfamily and reduction of sulphamethoxazole hydroxylamine in human and rat hepatic microsomes. Drug Metabolism and Disposition, 23, 406–414.
   PubMed Web of Science ®Google Scholar
• KADLUBAR, F. F., McKEE, E. M. and ZIEGLER, D. M., 1973, Reduced pyridine nucleotide-dependent N-hydroxy amine oxidase and reductase activities of hepatic microsomes. Archives of Biochemistry and Biophysics, 156, 46–57.
   PubMed Web of Science ®Google Scholar
• KADLUBAR, F. F. and ZIEGLER, D. M., 1974, Properties of a NADH-dependent N-hydroxy amine reductase isolated from pig liver microsomes. Archives of Biochemistry and Biophysics, 162, 83–92.
   PubMed Web of Science ®Google Scholar
• LIN, J., BEERKMAN, C. E. and CASHMAN, J. R., 1996, N-oxygenation of primary amines and hydroxylamines and retroreduction of hydroxylamines by adult human liver microsomes and adult fiavin-containing monooxygenase 3. Chemical Research in Toxicology, 9, 1183–1193.
   PubMed Web of Science ®Google Scholar
• LOWRY, O. H., ROSEBROUGH, N. J., FARR, A. L. and RANDALL, R. J., 1951, Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry, 193, 265–275.
   PubMed Web of Science ®Google Scholar
• MANDELL, G. L. and PETRI, W. A., 1996, Antimicrobial agents: sulfonamides, trimethoprim-sulpha-methoxazole, quinolones, and agents for urinary tract infections. In J. G. Hardman, L. E. Limbard, P. B. Molinoff, R. W. Ruddon and A. G. Gilman (eds), Goodman and Gilman's The Pharmacological Basis of Therapeutics (New York: McGraw-Hill), pp. 1057–1072.
   Google Scholar
• PRUEKSARITANONT, T., GORHAM, L. M., HOCHMAN, J. H., TRAN, L. O. and VYAS, K. P., 1996, Comparative studies of drug-metabolizing enzymes in dog, monkey, and human small intestines, and in Caco-2 cells. Drug Metabolism and Disposition, 24, 634–642.
   PubMed Web of Science ®Google Scholar
• RIEDER, M. J., KRAUSE, R. and BIRD, I. A., 1995, Time-course of toxicity of reactive sulphonamide metabolites. Toxicology, 95, 141–146.
   PubMedGoogle Scholar
• RIEDER, M. J., UETRECHT, J., SHEAR, N. H., CANNON, M., MILLER, M. and SPIELBERG, S. P., 1989, Diagnosis of sulphonamide hypersensitivity reactions by in-vitro rechallenge' with hydroxyl-amine metabolites. Annals of Internal Medicine, 110, 286–289.
   PubMed Web of Science ®Google Scholar
• RIEDER, M. J., UETRECHT, J., SHEAR, N. H. and SPIELBERG, S. P., 1988, Synthesis and in vitro toxicity of hydroxylamine metabolites of sulphonamides. Journal of Pharmacology and Experimental Therapeutics, 244, 724–728.
   PubMed Web of Science ®Google Scholar
• ROUSSEL, F., DUIGNAN, D. B., LAWTON, M. P., ORBACH, R. S., STRICK, C. A. and TWEEDIE, D. J., 1998, Expression and characterization of canine cytochrome P450 2D15. Archives of Biochemistry and Biophysics, 357, 27–36.
   PubMed Web of Science ®Google Scholar
• SHEAR, N. H., SPIELBERG, S. P., GRANT, D. M., TANG, B. K. and KALO W., 1986, Differences in metabolism of sulphonamides predisposes to idiosyncratic toxicity. Annals of Internal Medicine, 105, 179–184.
   PubMed Web of Science ®Google Scholar
• SHIMADA, H., HIRAI, K.-I., SIMAMURA, E. and PAN, J., 1998, Mitochondrial NADH-quinone oxidoreductase of the outer membrane is responsible for paraquat cytotoxicity in rat livers. Archives of Biochemistry and Biophysics, 351, 75–81.
   Google Scholar
• TESTA, B., 1995, Biochemistry of Redox Reactions (San Diego: Academic Press).
   Google Scholar
• TREPANIER, L. A., 1999, Delayed hypersensitivity reactions to sulphonamides: syndromes, pathogenesis, and management. Veterinary Dermatology, 10, 241–248.
   PubMed Web of Science ®Google Scholar
• TREPANIER, L. A., RAY, K., WINAND, N., SPIELBERG, S. P. and CRIBB, A. E., 1997, Cytosolic arylamine N-acetyltransfera deficiency in the dog and other canids due to an absence of NAT genes. Biochemical Pharmacology, 54, 73–80.
   PubMed Web of Science ®Google Scholar
• WOLKENSTEIN, P., CHARUE, D., LAURENT, P., REVUZ, J., ROUJEAU, J.-C. and BAGOT, M., 1995, Metabolic predisposition to cutaneous adverse drug reactions: role in toxic epidermal necrolysis caused by sulphonamides and anticonvulsants. Archives in Dermatology, 131, 544–551.
   Google Scholar